Inherited neurometabolic disorders represent a growing group of inborn errors of metabolism and many are potentially treatable. These inborn errors of metabolism are distinctly heterogeneous, both clinically and genetically. Advances in genetics have revolutionized the way we understand, diagnose and manage these inherited neurometabolic disorders. To date, more than 1,450 disorders have been included in the International Classification of Inherited Metabolic Disorders (ICIMD). Care for pediatric patients with neurometabolic disorders is, therefore, a rapidly expanding subspecialty in neurology. Early detection and early intervention in these disorders are invaluable in achieving normal or near-normal neurodevelopmental milestones for many patients.
(1) Anderson et al. provide a research article on novel insights into the monitoring of Ornithine transcarbamylase deficiency, focusing on the contribution of physiological processes and neurocognitive function in this population.
(2) Hu et al. retrospectively reviewed the clinical presentation, pathological features, genetic characteristics, and follow up of a cohort of mitochondrial myopathy in children from China, and preliminarily analyzed the risk factors and treatments correlated with the prognosis.
(3) Ortigoza-Escobar provides an overview of inborn metabolic errors that present movement disorders, suggests red flags and diagnostics clues for suspecting inborn errors of metabolism, and proposes minimum biochemical studies as stated in each movement disorder and the differential diagnoses according to the neuroradiological findings, providing evidence on symptomatic or disease specific-treatment through a six-step algorithm.
(4) Tabarki et al. review pediatric-onset metabolic disorders with Mendelian and mitochondrial inheritance and predominant spinal cord involvement. They provide an overview of these conditions, including background information and examples that require rapid identification, focusing on treatable conditions that would be catastrophic if they are not recognized.
(5) Tabarki et al. review reported literature on the inherited metabolic causes of stroke in children, focusing on mechanisms, types, and management.
(6) Alfadhel et al. retrospectively reviewed the spectrum of leukodystrophy in Saudi Arabia based on a multicentre study. A detailed description of the epidemiological, clinical, radiological, and genetic data of leukodystrophies is described.
(7) Hu et al. reported two Chinese patients with mitochondrial encephalopathy due to FOXRED1 mutations. They also did an extensive literature search on the same disorder.
(8) Almannai et al. present an overview of metabolic seizures based on various criteria such as treatability, age of onset, seizure type, and pathogenetic background.
These manuscripts represent an exciting and insightful snapshot of current knowledge of inherited neurometabolic disorders in children. State-of-the-art, existing challenges and emerging future topics are highlighted in this special issue.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Acknowledgments
The editors would like to thank all authors, reviewers, and guest editors for making this special research issue in Pediatric Neurometabolic Disorders possible.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
inherited neurometabolic disorders, movement disorders, leukodystrophy, stroke, mitochondrial disease
Citation
Tabarki B, Ortigoza-Escobar JD, Lee W-T and AlFadhel M (2021) Editorial: Pediatric Neurometabolic Disorders. Front. Neurol. 12:737398. doi: 10.3389/fneur.2021.737398
Received
06 July 2021
Accepted
09 July 2021
Published
07 September 2021
Volume
12 - 2021
Edited and reviewed by
Jo Madeleine Wilmshurst, University of Cape Town, South Africa
Updates
Copyright
© 2021 Tabarki, Ortigoza-Escobar, Lee and AlFadhel.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Brahim Tabarki btabarki@hotmail.com
This article was submitted to Pediatric Neurology, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.